ClinicalTrials.gg

What’s New Sign In

Biological

Therapeutic Autologous Lymphocytes clinical trials

studies test it: 17
open now: 0
in phase 3: 0
first study started: 1998

How studies write it

Studies that test it under each name

Name

therapeutic autologous lymphocytes: 15
autologous T cells: 7
AL: 5
Autologous Lymphocytes: 5

Studies by the year they started

17 studies that test it; most in 2002 (2)

By phase

A phase 1/2 study counts in both.

Phase 1: 16
Phase 2: 4

What it is tested for

Each study’s main condition, where its own words name it.

Melanoma: 5
Leukemia, Lymphocytic, Chronic, B-Cell: 1
Central Nervous System Neoplasms: 1
Glioblastoma: 1
Lymphoma: 1
Mesothelioma, Malignant: 1
Lymphoma, Non-Hodgkin: 1
Prostatic Neoplasms: 1
Adenocarcinoma: 1
Ovarian Neoplasms: 1
Colorectal Neoplasms: 1
Carcinoma, Renal Cell: 1

Who runs them

Industry 0 · Other 17

Fred Hutchinson Cancer Center (6) · Barbara Ann Karmanos Cancer Institute (2) · Memorial Sloan Kettering Cancer Center (1) · City of Hope Medical Center (1) · Gary Archer Ph.D. (1) · University of Pennsylvania (1) · Jonsson Comprehensive Cancer Center (1) · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)

Often tested with

Tested in the same studies.

Cyclophosphamide (7) · Aldesleukin (3) · Carmustine (2) · Cytarabine (2) · Etoposide (2) · Melphalan (2) · Tetanus Toxoid (1) · Cyclosporine (1)

Studies

Open first, then newest update. How each study uses Therapeutic Autologous Lymphocytes is read from its arms, and is right about nine times in ten.

Testing it · 17

Given in every arm · 8 — Therapeutic Autologous Lymphocytes is usual care beside what is tested